Chemring Group PLC (LSE:CHG) shares rose 0.19% to 534.5p in the latest market screen, gaining 1.00p and taking the defence technology group's market capitalisation to around £1.45 billion.
The shares have recently crossed above their 200-day moving average after recovering from a low near 500p in early October.
Key Highlights
On 14 October 2026, Chemring's Roke subsidiary signed a five-year agreement with a major US defence contractor worth at least $170 million, to supply Nav-Sync Miniature Radar Altimeters.
Roke received an initial $16 million production order, with deliveries beginning in October 2026. The relationship is expected to run to at least 2035.
Chemring previously reported record order intake, up 42% to £488 million in the six months to April.
Jefferies reiterated a Buy rating with a 658p target, and Berenberg a Buy with a 650p target.
About Chemring Group PLC
Chemring Group PLC (LSE:CHG) specialises in high-technology products and services for defence, security and aerospace.
It operates through Sensors & Information, including Roke, and Countermeasures & Energetics, which makes flares, propellants and energetic materials.
CEO Michael Ord leads the company.
Why Is LSE:CHG Up Today?
The 0.19% rise to 534.5p extends a recovery following the US contract win.
Rising global defence spending supports demand for Chemring's products.
Analysts remain positive, with targets well above the share price.
Key Reasons Behind the Uptick
One key factor is the US contract.
A second factor is defence spending.
Third, analyst support.
Fourth, record order book.
Key Growth Catalysts
The most important catalyst for LSE:CHG is the full-year results.
Energetics capacity expansion.
International contracts for Roke.
NATO restocking.
UK defence budget.
Risks
The main risk for LSE:CHG is UK defence market headwinds, which affect Roke.
Contract timing.
Execution risk in capacity expansion.
Insider selling earlier in the year.
Share price volatility.
Valuation
At 534.5p, Chemring has a market capitalisation of around £1.45 billion. The shares remain around 20% below their August high.
The key valuation question is whether order growth converts into earnings.
Capital Returns
Chemring pays dividends and has run share buybacks.
Capital returns are supported by cash generation.
What Investors Should Watch Next
Investors in LSE:CHG will watch the full-year results and further contract wins.
Overall, the 0.19% rise in LSE:CHG to 534.5p reflects a US contract win and defence demand. At the same time, UK market headwinds and execution remain key risks.






Please wait processing your request...